Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings Inc

Common Stock, $0.0001 par value · CUSIP: 21833P301

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Octagon Capital Advisors LP

    Shares: 955,000.00 · Class: 5.4%

  • Octagon Investments Master Fund LP

    Shares: 955,000.00 · Class: 5.4%

  • Ting Jia

    Shares: 955,000.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-26-001397
Form type
SCHEDULE 13G/A
Filer
Corbus Pharmaceuticals Holdings, Inc.
CIK
CIK 1595097
Filed
Feb 10, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub